Don't Give Too Much Weight to Yesterday<br />By Rev Shark<br />RealMoney.com Contributor<br />9/30/2009 8:23 AM EDT <br /><br />More firm and sure the hand of courage strikes, when it obeys the watchful eye of caution. <br />-- James Thomson<br /><br />On Tuesday the market failed to follow through on the big move we had on Monday. That is what you would normally expect when volume is low, but low-volume bounces have tended to just keep on going in this market. If you applied the normal rules of technical analysis, you would have missed on many of the strongest moves in this rally. <br /><br />It was just one day of a little softness, and it is premature to make too big of a deal of it. The market held on to most of Monday's gains and is still in good shape to consolidate a bit more and then make a run at yet another high. <br /><br />Plenty of bears are anxious to call a top in this market. They have been anxious for months now and have presented plenty of good reasons why will have to eventually pull back. They will be correct one of these days, but the market continues to do little to indicate its inevitable doom. We have a few minor warning signs, but there still isn't anything to indicate that the overall trend is changing or that a major change in character is taking place. <br /><br />We have to continue to respect the strong uptrend but keep our eyes open for signs that things may be shifting. The lack of follow-through was one of those signs that warrant some attention, but it is a fairly minor matter until we see some other action to confirm it. The fact that it is the end of the quarter may be helping to hold up the market more than would otherwise be the case, but that still isn't any reason to be overtly negative about things. <br /><br />The challenge of this market is not maintaining a positive mindset -- it's continuing to find ways to put money to work. There is no shortage of extended charts out there, and much of the speculative action is in low-priced and secondary names. It isn't a market with great leadership; rather, market players are constantly trying to find the hot pockets of action. <br /><br />We have some positive action this morning on good earnings from the likes of Nike (NKE) and Sealy (ZZ) , but Saks (SKS) and Darden (DRI) are offsetting things a bit to the downside. <br /><br />The market mood is fairly complacent, but we have ADP employment numbers coming up and the end-of-the-quarter pressures will be drying up. The bulls are still firmly in control -- above all else, we need to respect that. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: OMN +17.6%, ZZ +8.4%, JBL +7.5%, NKE +5.8% (also upgraded to Buy from Neutral at Goldman- Reuters)... M&A news: CFW +57.1% (Cano Petroleum and Resaca Exploitation announce plan to merge in a stock-for-stock transaction), CBY +1.4% (UK sets Kraft November 9 deadline for Cadbury bid - Reuters.com)... Select swine flu related stocks showing strength: APT +15.1%, SVA +7.2% (obtains second order of H1N1 vaccine from Chinese Central Government)... Select financial names showing strength: ING +4.4%, AZ +3.5%, AXA +3.4%, AEG +2.8%, IBN +2.7%, BCS +2.7%, LYG +1.5%, C +1.3%, AIG +1.2%... Select metals/mining names trading higher: HL +4.0%, EGO +3.8%, NGD +3.3%, SLW +3.2%, NG +3.0%, AUY +2.7%, GG +2.2%, AEM +2.0%, GDX +2.0%, GOLD +2.0%, ABX +1.9%, NEM +1.8%, GLD +1.1%... Other news: HOKU +58.9% (HOKU Scientific and Tianwei announce financing agreement; company to resume accelerated construction of polysilicon plant), DSCO +41.4% (Discovery Labs and FDA establish path for potential Surfaxin approval), SRLS +23.0% (announces two new contracts and that a third contract has been expanded; new funding of $10.8 mln), TSTR +22.1% (TerreStar and AT&T to bring to market the first fully integrated satellite cellular smartphone), CPD +21.1% (enters into consent decree with FDA providing path to resume manufacturing operations), PZE +20.3% (still checking), ICCC +19.0% (Mastitis drug meets pivotal effectiveness study end point), REXX +13.4% (still checking), EBS +9.5% (announces that NIAID to fund development of advanced anthrax vaccine candidate), HDY +9.1% (to hold business update investor conference call September 30 at 10 a.m. CT), AMSC +8.7% (Am Superconductor and Sinovel Sign $100 million follow-on electrical components contract for 3 megawatt wind turbines), XOMA +8.6% (presents results demonstrating novel mechanism of action for XOMA 052 in regulating IL-1 Beta Levels), RBS +3.1% (still checking), GVA +3.0% (Granite Construction joint venture team awarded $659 mln contract to build Queens Bored Tunnels and structures in New York), AMP +3.0% (to acquire long-term asset management business of Columbia Management for approximately $1 billion), WIN +2.0% (prices private offering of $400 mln of Its 7.875% senior notes due 2017), OREX +1.9% (announces the results of a Phase 2b trial for Empatic on Sept 30, 2009 before the markets open)... Analyst comments: SLTM +10.0% (light volume; initiated with a Buy at Canaccord), AMSC +9.3% (upgraded to Buy at Kaufman), IFNNY +8.0% (upgraded to Outperform from Neutral at Exane BNP Paribas), VVUS +6.7% (tgt range raised to $16-18 at Merriman following positive Qnexa results and equity-offering), HBAN +2.7% ( upgraded to Buy from Hold at Deutsche Bank), CVH +2.3% (upgraded to Outperform from Market Perform at BMO Capital Markets), ADM +2.3% (upgraded to Outperform from Market Perform at BMO Capital Markets), NVS +1.8% (upgraded to Buy at Citigroup), COV +1.8% (added to Conviction Buy list at Goldman- Reuters). <br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: ICON -15.8%, DRI -6.1%, ATU -2.9%, WOR -1.8%... Other news: CIT -37.3% (CIT Group near plan to turn over company to bondholders - Reuters), SMOD -6.5% (still checking), SOL -6.0% (still checking), FR -4.9% (announces pricing of public offering of 12,500,000 shares of common stock at $5.25), CHBT -4.7% (prices public offering of 4,600,000 shares of its common stock at $15.00 per share), SSS -4.7% (announces that it has commenced a public offering of 3 mln shares of common stock), SKS -4.6% (files for $100 mln common stock offering), OREX -4.3% (announces Phase 2b Trial for Empatic results), HTS -3.9% (trading ex dividend), AGNC -3.8% (trading ex dividend), CLP -3.3% (commences 9 mln common share offering), MOG.A -2.1% (prices public offering of 2.5 mln shares at $29.50 per share)... Analyst comments: GLBC -2.9% (downgraded to Hold at Citigroup), RAIL -2.7% (downgraded to Hold at Keybanc), TGT -1.4% (downgraded to Neutral at UBS), WLP -1.2% (downgraded to Market Perform from Outperform at BMO Capital Markets), GHL -1.1% (downgraded to Neutral from Buy at Pali Capital).